PROCÉDÉS DE TRAITEMENT DU CANCER AU MOYEN D'UN ACIDE NUCLÉIQUE CIBLANT MDM2

• 收藏
• 分享

专利权人:

Phio Pharmaceuticals Corp.

发明人:

BYRNE, Michael,BULOCK, Karen, G.,CARDIA, James

申请号：

EP15785528

公开号：

EP3137119B1

申请日:

2015.04.28

申请国别(地区):

EP

年份:

2020

代理人:

摘要：

Aspects of the invention relate to methods for treating cancer by administering to a subject in need thereof a therapeutically effective amount of a nucleic acid molecule that is directed against a gene encoding mouse double minute 1 homolog (MDM1), mouse double minute 2 homolog (MDM2), mouse double minute 3 homolog (MDM3), mouse double minute 4 homolog (MDM4) or V-myc myelocytomatosis viral related oncogene (MYCN) for treating cancer. Further aspects of the invention relate to nucleic acid molecules and compositions comprising nucleic acid molecules.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/